Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials

Yeh, C., Zhou, M., Bapodra, N., Hershman, D., Espinal, E., Moran, M., Rivero, M., Fojo, A. T., & Bates, S. E. (2023). Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials. Breast Cancer Research and Treatment, 204(1), 39–47. https://doi.org/10.1007/s10549-023-07131-7
Authors:
Celine Yeh
Mengxi Zhou
Neil Bapodra
Dawn Hershman
Edward Espinal
Marina Moran
Maria Rivero
Antonio Tito Fojo
Susan E Bates
Affiliated Authors:
Celine Yeh
Mengxi Zhou
Dawn Hershman
Antonio Tito Fojo
Susan E Bates
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Pyridines (MeSH)
Author Keywords:
abemaciclib
cdk4/6
cdk4/6 inhibitors
overall survival
paloma
ribociclib
elink
Publication Type:
Article
Unique ID:
10.1007/s10549-023-07131-7
PMID:
37955764
DOI:
10.1007/s10549-023-07131-7
Journal:
Breast Cancer Research and Treatment
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: